REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 36 filers reported holding REGULUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $7,000 | -69.6% | 34,188 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | -53.1% | 34,188 | -49.3% | 0.00% | – |
| Q1 2018 | $49,000 | +25.6% | 67,448 | +83.5% | 0.00% | – |
| Q4 2017 | $39,000 | -9.3% | 36,752 | +7.5% | 0.00% | – |
| Q3 2017 | $43,000 | +79.2% | 34,189 | +39.8% | 0.00% | – |
| Q2 2017 | $24,000 | -87.5% | 24,459 | -79.0% | 0.00% | – |
| Q1 2017 | $192,000 | -35.8% | 116,400 | -12.6% | 0.00% | – |
| Q4 2016 | $299,000 | -33.8% | 133,219 | -2.6% | 0.00% | – |
| Q3 2016 | $452,000 | +10.8% | 136,777 | -3.1% | 0.00% | – |
| Q2 2016 | $408,000 | -51.4% | 141,216 | +16.6% | 0.00% | – |
| Q1 2016 | $839,000 | -25.8% | 121,098 | -6.6% | 0.00% | – |
| Q4 2015 | $1,130,000 | +47.3% | 129,625 | +10.5% | 0.00% | – |
| Q3 2015 | $767,000 | -50.3% | 117,302 | -16.6% | 0.00% | – |
| Q2 2015 | $1,542,000 | +24.2% | 140,704 | +91.8% | 0.00% | – |
| Q1 2015 | $1,242,000 | +6.2% | 73,344 | +0.5% | 0.00% | – |
| Q4 2014 | $1,170,000 | +170.2% | 72,971 | +15.1% | 0.00% | – |
| Q3 2014 | $433,000 | -57.5% | 63,398 | -50.0% | 0.00% | – |
| Q2 2014 | $1,018,000 | +92.4% | 126,712 | +116.2% | 0.00% | – |
| Q1 2014 | $529,000 | +21.1% | 58,613 | -1.0% | 0.00% | – |
| Q4 2013 | $437,000 | -59.8% | 59,183 | -48.7% | 0.00% | – |
| Q3 2013 | $1,088,000 | +91.5% | 115,418 | +99.6% | 0.00% | – |
| Q2 2013 | $568,000 | – | 57,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|